益诺思：股东减持股份计划公告

Core Points - Yinos's announcement on November 28 indicates that Zhangjiang Biopharmaceutical Base holds 11,020,753 shares of Yinos, representing 7.82% of the total share capital [2] - Zhangjiang Biopharmaceutical Base plans to reduce its holdings by up to 1,409,796 shares, which is no more than 1.00% of the total share capital, within three months after the announcement [2] - The reduction will be executed through centralized bidding and will not exceed 1.00% of the total shares within any consecutive 90-day period [2]